NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/14/2025
Back to search
Official data from USPTO
ONCOLYTICS BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOLYTICS BIOTECH
ST13
US500000086255705Class
5
Filing
86255705
Registration
4784261
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
12/09/2025
Trademark type
Word
Nice classes
5
Filing date
04/17/2014
Registration date
08/04/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/21/2000
First use in commerce
11/14/2005
Drawing code
4
Owner type
03
Owner location
Calgary, Alberta, CA
Examiner
BUTLER, MIDGE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Oncolytics Biotech Inc.
Representatives
John P. McCormick FISH & RICHARDSON P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Housemark for pharmaceutical products; pharmaceutical preparations for use in the treatment of cancer
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/14/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/14/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/29/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/04/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/03/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/03/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2021
E815
TEAS SECTION 8 & 15 RECEIVED
07/28/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/04/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/04/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2015
PUBO
PUBLISHED FOR OPPOSITION
05/19/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/11/2015
ALIE
ASSIGNED TO LIE
04/11/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
03/23/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/23/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
03/23/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/23/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/27/2014
GNRT
NON-FINAL ACTION E-MAILED
10/27/2014
CNRT
NON-FINAL ACTION WRITTEN
10/27/2014
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/12/2014
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/26/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/09/2014
ALIE
ASSIGNED TO LIE
08/05/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
07/28/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/28/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
07/28/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/28/2014
DOCK
ASSIGNED TO EXAMINER
07/28/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2014
NWAP
NEW APPLICATION ENTERED
04/21/2014
Continuous trademark protection
Get notified about every new filing that threatens ONCOLYTICS BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.